Mirror-image cyclodextrin won C&EN’s Molecule of the Year for 2024, thanks for voting!
On December 18, 2024, Chemical & Engineering News (C&EN)—a weekly news magazine published by the American Chemical Society with the
Category: CD derivatives
Mirror-image cyclodextrin makes it into C&EN’s Molecules of the Year for 2024 list; please, vote!
Mirror-image cyclodextrins (CDs), or L-CDs, which have already been elaborated by unnatural product synthesis (1) from commercially available L-glucose and
Catalyzing Global Health through Glycoscience Knowledge
This Gordon Research Seminar “Catalyzing Global Health through Glycoscience Knowledge” will be held on June 15 – 20, 2025 in
Modified β-cyclodextrin compounds as enhanced eco-friendly and easily accessible corrosion inhibitors for carbon steel in hydrochloric acid
β-CD was esterified independently with two distinct ionic liquids to evaluate their potential as corrosion inhibitors for carbon steel in
Cyclodextrin polymer as superhydrophilic and underwater superoleophobic coating of membrane for efficient oil/water emulsion separation
In this research, superhydrophilic and underwater superoleophobic coatings on poly(vinylidene fluoride) (PVDF) membrane are constructed via interfacial polymerization following “thiol-ene” click reaction.
Long in vivo circulating nanomicelles formed by sharp-contrast Janus star polymers derived from β-cyclodextrin grafted with lipids and polyzwitterions
This work reports a rational design of a sharp-contrast Janus star polymer (SJSP) consisting of multiple arms of superhydrophobic lipid
Supramolecular Diagnostic Tool: A Freshly Approved HPBCD-Enabled Radioactive Drug Formulation
On September 27, 2024 GE HealthCare announced that the U.S. Food and Drug Administration (FDA) has granted approval of Flyrcado™
Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model
β-cyclodextrin polymers were prepared using radical polymerization with co-monomers, 6-deoxy-6-(2-methacryloyloxyethylsuccinamide)-β-cyclodextrin (CD-MSAm) and N,N,N-trimethyl-N-(2-hydroxy-3-metacryloyloxopropyl)-ammonium chloride (QA) to design cyclodextrins suitable for
The revival of cyclodextrins as active pharmaceutical ingredients
Cyclodextrins have long been known as host molecules, a special feature that has led to their widespread use in a
Merck is about to perform post-marketing safety study of HPBCD-containing PREVYMIS™ injection
Merck Sharp and Dohme LLC. has received initial U.S. Approval: 2017 PREVYMIS™ (letermovir) injection, for intravenous use. In the first